BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20220313T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20221106T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20230312T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20231105T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20240310T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20241103T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231003
DTEND;VALUE=DATE:20231006
DTSTAMP:20230916T150439Z
CREATED:20230916T150439Z
LAST-MODIFIED:20230916T150439Z
UID:59214-1696291200-1696550399@globalbiodefense.com
SUMMARY:OneLab Summit 2023
DESCRIPTION:The CDC will host the OneLab Summit 2023 from 3-5 October 2023 online. This free\, three-day virtual summit connects laboratory professionals in real time to support a unified response to laboratory training needs. \nAttendance is open to anyone interested or involved in the laboratory profession. OneLab Summit programming is most relevant to people who provide education or training to clinical and public laboratory professionals. \nHighlighted topics include: \n\nMaximizing Lessons Learned from Past Outbreaks to Develop a Sustainable Laboratory Cross-training Program\nBiosafety Plan: Preparing Your Laboratory to Handle Emerging and Re-Emerging Pathogens\nHow Laboratories Should Prepare for Future Responses\nEvaluating Your Laboratory’s Risk Management Process Or Quality Improvement Process\nThe Role and Importance of DEIAB in Public Health Workforce Development to Advance Health Equity\nInterconnecting People for Planning and Preparedness\nOneLab REACH – What’s New and What’s Ahead\nUnderstanding CLIA and CAP Regulations to Advance Your Laboratory Career\nCreating a Training Needs Assessment For Your Laboratory\nLaboratory Staffing and Retention\nInnovative Student Recruitment to MLS and MLT Programs\n\nThis year\, OneLab Summit will feature a Virtual Exhibit Hall. Attendees can use this online space to highlight their organization’s programs\, resources\, success stories\, and more. \nPlease visit CDC’s OneLab Summit 2023 website to register.
URL:https://globalbiodefense.com/event/onelab-summit-2023/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:https://cdc.zoomgov.com/webinar/register/WN_tANOotpLSduPLwmczNXDVA#/registration
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231003T120000
DTEND;TZID=America/New_York:20231003T140000
DTSTAMP:20231008T183147Z
CREATED:20230922T155901Z
LAST-MODIFIED:20231008T183147Z
UID:59305-1696334400-1696341600@globalbiodefense.com
SUMMARY:Public-Private Partnerships to Distribute\, Dispense\, and Administer Medical Countermeasures
DESCRIPTION:The National Academies will host a workshop on “Public-Private Partnerships for Data-Informed Decision-Making to Distribute\, Dispense\, and Administer Medical Countermeasures” on October 3\, 2023.\n \nLessons learned from past health emergencies highlight the importance of public-private partnerships to facilitate and accelerate the research\, development\, and manufacturing of vaccines\, therapeutics\, and diagnostics (i.e.\, medical countermeasures). However\, less attention was given to public-private partnerships that enabled the successful implementation (distribution\, dispensing\, monitoring\, uptake\, and utilization) of medical countermeasures (MCMs)\, also known as the “last-mile.” \nThis is part of the Medical Countermeasures- Expanding Delivery and Increasing Uptake Through Public-Private Partnerships workshop series hosted by the National Academies Forum on Medical and Public Health Preparedness for Disasters and Emergencies. The series aims to examine lessons learned and future opportunities for public-private partnerships to facilitate the implementation of medical countermeasures to the public during a public health emergency. Speakers throughout the series will highlight various public-private partnership models deployed during recent health emergencies and discuss potential paths forward for public-private partnerships to facilitate successful implementation of medical countermeasures. \nVisit NASEM’s Medical Countermeasures- Expanding Delivery and Increasing Uptake Through Public-Private Partnerships workshop website to register.
URL:https://globalbiodefense.com/event/public-private-partnerships-to-distribute-dispense-and-administer-medical-countermeasures/
CATEGORIES:Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231004T100000
DTEND;TZID=America/New_York:20231004T140000
DTSTAMP:20230421T224948Z
CREATED:20230421T224941Z
LAST-MODIFIED:20230421T224948Z
UID:57010-1696413600-1696428000@globalbiodefense.com
SUMMARY:Tunneling Nanotubes and Intracellular Protrusions Workshop
DESCRIPTION:The Tunneling Nanotubes and Intracellular Protrusions Workshop will be hosted 4 October 2023 by the Federation of American Societies for Experimental Biology (FASEB). \nThis FASEB Catalyst Conference will be an exciting forum for discussing new discoveries in the field of tunneling nanotubes and related cell protrusions\, and their potential implications for human disease. \nIn the past decade\, there has been an increased focus on novel cellular extensions and their potential roles in facilitating human diseases\, including neurologic diseases\, viral infectious diseases\, cancer\, and others. One of the exciting new aspects of this field is improved characterization and understanding of the functions and potential mechanisms of tunneling nanotubes (TNTs). TNTs are actin-based filamentous protrusions that are structurally distinct from filopodia. They form and connect cells at long distance and serve as direct conduits for intercellular communication in a wide range of cell types in vitro and in vivo. \nResearchers are increasingly entering this field and investigating the role of TNTs in mediating cancer cell invasion and drug resistance\, cellular transfer of proteins\, RNA or organelles\, and intercellular spread of infectious agents\, such as viruses\, bacteria and prions. \nPlease visit FASEB’s Tunneling Nanotubes and Intercellular Protrusions Workshop site to register.
URL:https://globalbiodefense.com/event/tunneling-nanotubes-and-intracellular-protrusions-workshop/
CATEGORIES:Workshop
LOCATION:https://us06web.zoom.us/webinar/register/WN_Lz8ZIPsdT6-vNzJ2xnwjFA#/registration
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231012T120000
DTEND;TZID=America/New_York:20231012T140000
DTSTAMP:20230922T160758Z
CREATED:20230922T160650Z
LAST-MODIFIED:20230922T160758Z
UID:59309-1697112000-1697119200@globalbiodefense.com
SUMMARY:Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures
DESCRIPTION:The National Academies will host a workshop on “Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures” on 12 October 2023.\n \nLessons learned from past health emergencies highlight the importance of public-private partnerships to facilitate and accelerate the research\, development\, and manufacturing of vaccines\, therapeutics\, and diagnostics (i.e.\, medical countermeasures). However\, less attention was given to public-private partnerships that enabled the successful implementation (distribution\, dispensing\, monitoring\, uptake\, and utilization) of medical countermeasures (MCMs)\, also known as the “last-mile.” \nThis is part of the Medical Countermeasures- Expanding Delivery and Increasing Uptake Through Public-Private Partnerships workshop series hosted by the National Academies Forum on Medical and Public Health Preparedness for Disasters and Emergencies. The series aims to examine lessons learned and future opportunities for public-private partnerships to facilitate the implementation of medical countermeasures to the public during a public health emergency. Speakers throughout the series will highlight various public-private partnership models deployed during recent health emergencies and discuss potential paths forward for public-private partnerships to facilitate successful implementation of medical countermeasures. \nVisit NASEM’s Medical Countermeasures- Expanding Delivery and Increasing Uptake Through Public-Private Partnerships workshop website to register.
URL:https://globalbiodefense.com/event/public-private-partnerships-for-acceptance-and-uptake-of-medical-countermeasures/
CATEGORIES:Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231017T120000
DTEND;TZID=America/New_York:20231017T140000
DTSTAMP:20230922T161025Z
CREATED:20230922T161025Z
LAST-MODIFIED:20230922T161025Z
UID:59311-1697544000-1697551200@globalbiodefense.com
SUMMARY:Public-Private Partnerships for Dispensing and Administration of Medical Countermeasures
DESCRIPTION:The National Academies will host a workshop on “Public-Private Partnerships for Dispensing and Administration of Medical Countermeasures” on 17 October 2023.\n \nLessons learned from past health emergencies highlight the importance of public-private partnerships to facilitate and accelerate the research\, development\, and manufacturing of vaccines\, therapeutics\, and diagnostics (i.e.\, medical countermeasures). However\, less attention was given to public-private partnerships that enabled the successful implementation (distribution\, dispensing\, monitoring\, uptake\, and utilization) of medical countermeasures (MCMs)\, also known as the “last-mile.” \nThis is part of the Medical Countermeasures- Expanding Delivery and Increasing Uptake Through Public-Private Partnerships workshop series hosted by the National Academies Forum on Medical and Public Health Preparedness for Disasters and Emergencies. The series aims to examine lessons learned and future opportunities for public-private partnerships to facilitate the implementation of medical countermeasures to the public during a public health emergency. Speakers throughout the series will highlight various public-private partnership models deployed during recent health emergencies and discuss potential paths forward for public-private partnerships to facilitate successful implementation of medical countermeasures. \nVisit NASEM’s Medical Countermeasures- Expanding Delivery and Increasing Uptake Through Public-Private Partnerships workshop website to register.
URL:https://globalbiodefense.com/event/public-private-partnerships-for-dispensing-and-administration-of-medical-countermeasures/
CATEGORIES:Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231022
DTEND;VALUE=DATE:20231026
DTSTAMP:20230421T235537Z
CREATED:20230421T235537Z
LAST-MODIFIED:20230421T235537Z
UID:57022-1697932800-1698278399@globalbiodefense.com
SUMMARY:Tissue\, Matrix\, and Pathobiology: Joint Meeting of ASMB\, HCS\, and ASIP
DESCRIPTION:Tissue\, Matrix\, and Pathobiology will be held 22-25 October 2023 in Salt Lake City\, Utah. \nThis event is an exciting new multidisciplinary and collaborative joint meeting of the American Society for Matrix Biology (ASMB)\, The Histochemical Society (HCS)\, and the American Society for Investigative Pathology (ASIP). \nWho Should Attend\nStudents\, trainees\, investigators\, and educators who are working on cutting-edge basic\, clinical\, and translational research related to biology of cells and tissues\, as well as molecular and cellular alterations that drive disease processes. \nScientific Programming\nThe scientific program includes award lectures\, plenary sessions\, symposia\, and workshops featuring speakers who are leaders in their respective fields of study. Thematic highlights include: \n\nExtracellular Matrix Biology\nLiver Pathobiology\nCardiovascular Diseases\nECM Receptors\nPathobiology of Fibrosis\nCancer Pathobiology\nMatrix Disorders\nNeuropathology\nOrganoid Models of Disease\nMechanobiology\nInflammatory and Infectious diseases\nCell-Matrix Interactions\n\nHighlighted presentations include: \n\nMucosal Pathobiology – Cellular and Microbial Cross-Talk on the Mucosal Interfaces\nLiver Pathobiology – Mechanisms of Hepatoxicity and Liver Injury\nThe Tissue Engineering and Regenerative Medicine International Society\, Inc. (TERMIS)\nHigher Order Multi-Analyte Interrogation of Tissue\nViral Persistence (What Did COVID Teach Us About Preparing for the Next Pandemic)\nCardiovascular Pathobiology – Ramifications of SARS-CoV-2 Infection on the Heart\nLiver Pathobiology – Liver Growth Control: From Maintenance and Regeneration to Disease\nMatrix Degradation: MMPs\, ADAMTS\, Proteases\nNeuropathology and Neuro-Inflammation\nOrganoids to Study ECM Signaling\nInfection and ECM\nMatricellular Proteins\nRespiratory Viral Pathogens\nInfectious Disease – Utilizing Alternative Model Systems to Study Infectious Diseases\nDigital Pathology and Artificial Intelligence Applications in the Biotech Industry\nOrganoids and 3-D Models\n\nThe meeting will also feature education and career development sessions that are focused on the needs of the current generation of trainees and young investigators. A generous scholar award program will provide travel grants for trainees and junior faculty who are members of the participating Societies. \nPlease visit ASIP’s Tissue\, Matrix\, and Pathobiology 2023 Joint Meeting website for more information and to register.
URL:https://globalbiodefense.com/event/tissue-matrix-and-pathobiology-joint-meeting-of-asmb-hcs-and-asip/
LOCATION:The Grand America Hotel\, 555 Main St\, Salt Lake City\, UT\, 84111\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231026T120000
DTEND;TZID=America/New_York:20231026T140000
DTSTAMP:20230922T161311Z
CREATED:20230922T161228Z
LAST-MODIFIED:20230922T161311Z
UID:59314-1698321600-1698328800@globalbiodefense.com
SUMMARY:Public-Private Partnerships for Distribution of Medical Countermeasures
DESCRIPTION:The National Academies will host a workshop on “Public-Private Partnerships for Distribution of Medical Countermeasuress” on 26 October 2023.\n \nLessons learned from past health emergencies highlight the importance of public-private partnerships to facilitate and accelerate the research\, development\, and manufacturing of vaccines\, therapeutics\, and diagnostics (i.e.\, medical countermeasures). However\, less attention was given to public-private partnerships that enabled the successful implementation (distribution\, dispensing\, monitoring\, uptake\, and utilization) of medical countermeasures (MCMs)\, also known as the “last-mile.” \nThis is part of the Medical Countermeasures- Expanding Delivery and Increasing Uptake Through Public-Private Partnerships workshop series hosted by the National Academies Forum on Medical and Public Health Preparedness for Disasters and Emergencies. The series aims to examine lessons learned and future opportunities for public-private partnerships to facilitate the implementation of medical countermeasures to the public during a public health emergency. Speakers throughout the series will highlight various public-private partnership models deployed during recent health emergencies and discuss potential paths forward for public-private partnerships to facilitate successful implementation of medical countermeasures. \nVisit NASEM’s Medical Countermeasures- Expanding Delivery and Increasing Uptake Through Public-Private Partnerships workshop website to register.
URL:https://globalbiodefense.com/event/public-private-partnerships-for-distribution-of-medical-countermeasures/
CATEGORIES:Webinar-Webcast
LOCATION:
END:VEVENT
END:VCALENDAR